Epidemiology and clinical features of community‐acquired, healthcare‐associated and nosocomial bloodstream infections in tertiary‐care and community hospitals J Rodríguez‐Baño, MD López‐Prieto, MM Portillo, P Retamar, C Natera, ... Clinical Microbiology and Infection 16 (9), 1408-1413, 2010 | 164 | 2010 |
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus–coinfected patients with compensated cirrhosis JA Mira, A Rivero-Juárez, LF López-Cortés, JA Girón-González, F Téllez, ... Clinical Infectious Diseases 56 (11), 1646-1653, 2013 | 112 | 2013 |
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis N Merchante, A Rivero‐Juárez, F Téllez, D Merino, M José Ríos‐Villegas, ... Hepatology 56 (1), 228-238, 2012 | 107 | 2012 |
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain N Merchante, E Merino, J López-Aldeguer, F Jover, ... Clinical Infectious Diseases 56 (1), 143-150, 2013 | 95 | 2013 |
Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis JA Pineda, E Recio, Á Camacho, J Macías, C Almodóvar, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (4), 445-449, 2009 | 59 | 2009 |
Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus–infected patients with nonalcoholic fatty liver disease J Macías, M Mancebo, D Merino, F Téllez, ML Montes-Ramírez, F Pulido, ... Clinical Infectious Diseases 65 (6), 1012-1019, 2017 | 56 | 2017 |
Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C JA Pineda, R Nunez-Torres, F Téllez, M Mancebo, F García, N Merchante, ... Journal of Infection 71 (5), 571-577, 2015 | 51 | 2015 |
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy J Macías, LE Morano, F Téllez, R Granados, A Rivero-Juárez, R Palacios, ... Journal of hepatology 71 (1), 45-51, 2019 | 47 | 2019 |
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients J Macías, A Camacho, MA Von Wichmann, LF Lopez-Cortés, E Ortega, ... Aids 27 (16), 2541-2549, 2013 | 43 | 2013 |
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort … K Neukam, LE Morano-Amado, A Rivero-Juarez, M Mancebo, ... HIV Clinical Trials 18 (3), 126-134, 2017 | 40 | 2017 |
Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort P Retamar, MD López-Prieto, F Rodriguez-Lopez, M de Cueto, MV Garcia, ... International Journal of Infectious Diseases 26, 83-87, 2014 | 36 | 2014 |
Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis N Merchante, A Rivero-Juárez, F Téllez, D Merino, MJ Ríos-Villegas, ... Aids 31 (4), 493-500, 2017 | 32 | 2017 |
Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy J Macías, M Márquez, F Téllez, D Merino, P Jiménez-Aguilar, ... Clinical infectious diseases 57 (10), 1401-1408, 2013 | 27 | 2013 |
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals AYM Howe, C Rodrigo, EB Cunningham, MW Douglas, J Dietz, J Grebely, ... JHEP Reports 4 (5), 100462, 2022 | 26 | 2022 |
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy J Dietz, VC Di Maio, A de Salazar, D Merino, J Vermehren, S Paolucci, ... Journal of Hepatology 74 (4), 801-810, 2021 | 24 | 2021 |
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in clinical practice even with previous virological failures to protease inhibitor-based regimens LF Lopez-Cortes, MA Castano, MA Lopez-Ruz, MJ Rios-Villegas, ... PLoS One 11 (2), e0148924, 2016 | 24 | 2016 |
Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals J Macias, A Rivero-Juarez, K Neukam, F Tellez, D Merino, M Frias, ... Aids 29 (15), 1927-1935, 2015 | 24 | 2015 |
Response to Pegylated Interferon plus Ribavirin among HIV/Hepatitis C Virus–coinfected patients with compensated liver cirrhosis JA Mira, S García-Rey, A Rivero, I de los Santos-Gil, LF López-Cortés, ... Clinical infectious diseases 55 (12), 1719-1726, 2012 | 23 | 2012 |
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C J Macías, K Neukam, J Portilla, JA Iribarren, I de Los Santos, A Rivero, ... Journal of antimicrobial chemotherapy 66 (6), 1346-1350, 2011 | 23 | 2011 |
Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection J Macías, R Granados, F Téllez, D Merino, M Pérez, LE Morano, ... Journal of viral hepatitis 26 (1), 16-24, 2019 | 21 | 2019 |